Home › Thyroid Cancer › Massachusetts
Thyroid Cancer clinical trials in Massachusetts
8 studies for Thyroid Cancer are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
- Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06959511Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- Dana-Farber Cancer Institute, Boston
RecruitingPhase 2
Ages 2 to 99 · All sexes · Updated Oct 21, 2026 · NCT05783323Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Massachusetts General Hospital, Boston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06239194Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Dana-Farber Cancer Institute, Boston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT05786924XL092 and Cemiplimab in BRAF WT Thyroid Cancer
- Dana Farber/Harvard Cancer Center, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06902376Integrated Cancer Repository for Cancer Research
- Holyoke Medical Center, Holyoke
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Hereditary Risk Factors for Thyroid Cancer
- Dana Farber Cancer Institute, Boston
RecruitingHealthy volunteers welcome
All ages · All sexes · Updated Jun 11, 2026 · NCT02747888A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Massachusetts General Hospital,, Boston
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.